Literature DB >> 11522066

Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry.

F Baud-Camus1, P Marquet, M Soursac, C Davrinche, R Farinotti.   

Abstract

A rapid, sensitive method using liquid chromatography-electrospray mass spectrometry (LC-ES-MS) was developed and evaluated for the simultaneous quantitative determination of caffeine metabolites 1U, 1X and AAMU in human urine. This method involved a simple dilution of urine samples. The chromatographic separation was achieved on a C18 reversed-phase column using a gradient of acetonitrile in 2 mM, pH 3.0 ammonium formate as mobile phase. After ionisation in an electrospray source, mass spectrometric detection was performed in the negative ion, selected ion monitoring mode. This method yielded acceptable accuracy and precision within the range 0.25-50 microg/ml. This analytical method was applied to investigate the N-acetylator phenotype of HIV-infected patients and compared with high-performance liquid chromatography with UV detection. Its specificity was better, which appeared to be absolutely necessary to prevent errors in metabolic ratios and phenotype interpretation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522066     DOI: 10.1016/s0378-4347(01)00246-8

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

Review 1.  Metabolomics and its role in understanding cellular responses in plants.

Authors:  Ritu Bhalla; Kothandaraman Narasimhan; Sanjay Swarup
Journal:  Plant Cell Rep       Date:  2005-11-16       Impact factor: 4.570

2.  Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure.

Authors:  Alexander Jetter; Martina Kinzig-Schippers; Michael Illauer; Robert Hermann; Katharina Erb; Jürgen Borlak; Helga Wolf; Gillian Smith; Ingolf Cascorbi; Fritz Sörgel; Uwe Fuhr
Journal:  Eur J Clin Pharmacol       Date:  2004-01-28       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.